24 March 2021 | 16:00 – 17:00
with Neurix COO Sébastien Mosser and
InnoSer oncology study director Kim Frederix
WHAT IS IT ABOUT?
A platform for glioblastoma drug development
In vivo like in vitro environment
Derived from patient human cells, BlastomaBrain makes a 3D drug screening platform for glioblastoma tumors, providing results that cannot readily be replicated in 2D cultures.
InnoSer offers BlastomaBrain platform as a service for glioblastoma drug development. With our scientific expertise and state-of-the-art facilities, we provide you fast and reliable results.
SIGN UP HERE
Your place at this webinar is just a few clicks away!
Please use the sign up form here to register for the webinar. You can scroll down within the embedded window and easily fill out the form. Overall, we expect to spend approximately 45min on introducing the platform to you as well as discussing its applications.
Cannot attend the webinar? You can still register and receive the recording afterwards.
We will reserve time for your questions but you can always feel free to direct your questions to our business development managers via their contact info below.
We look forward to welcoming you to our event!
Having trouble with Captcha?
- Visit registration page in a new window.
- Reach out via the contact form below to register manually. We are happy to help!
- Sign in and use the Zoom App or Web SDK to avoid any issues.